What is Ainos Inc's earnings per share (EPS)?

Ainos Inc (AIMD) reported diluted earnings per share of $-3.46 for fiscal year 2025. This represents a -121.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Ainos Inc Financials

AIMD

Source SEC Filings (10-K/10-Q) Updated Mar 30, 2026 Currency USD FYE March

This page shows Ainos Inc (AIMD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Low Quality

0.31x

For every $1 of reported earnings, Ainos Inc generates $0.31 in operating cash flow (-$4.6M OCF vs -$14.8M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-19.7x

Ainos Inc earns $-19.7 in operating income for every $1 of interest expense (-$14.0M vs $712K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$124K

YoY+499.0%

5Y CAGR+49.6%

Ainos Inc generated $124K in revenue in fiscal year 2025. This represents an increase of 499.0% from the prior year.

EBITDA

-$9.2M

YoY-1.9%

Ainos Inc's EBITDA was -$9.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 1.9% from the prior year.

Net Income

-$14.8M

YoY+0.6%

Ainos Inc reported -$14.8M in net income in fiscal year 2025. This represents an increase of 0.6% from the prior year.

EPS (Diluted)

$-3.46

YoY-121.8%

Ainos Inc earned $-3.46 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 121.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$4.6M

YoY+20.2%

Ainos Inc generated -$4.6M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 20.2% from the prior year.

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

YoY+135.5%

5Y CAGR-29.6%

10Y CAGR-9.7%

Ainos Inc had 7M shares outstanding in fiscal year 2025. This represents an increase of 135.5% from the prior year.

Margins & Returns

Gross Margin

82.9%

YoY+236.6pp

5Y CAGR+51.0pp

Ainos Inc's gross margin was 82.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 236.6 percentage points from the prior year.

Operating Margin

-11268.3%

YoY+55503.9pp

5Y CAGR-2571.6pp

Ainos Inc's operating margin was -11268.3% in fiscal year 2025, reflecting core business profitability. This is up 55503.9 percentage points from the prior year.

Net Margin

-11897.0%

YoY+59805.2pp

5Y CAGR-3138.8pp

Ainos Inc's net profit margin was -11897.0% in fiscal year 2025, showing the share of revenue converted to profit. This is up 59805.2 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$947K

YoY-88.7%

5Y CAGR+375.7%

Ainos Inc invested $947K in research and development in fiscal year 2025. This represents a decrease of 88.7% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$35K

YoY+62.0%

10Y CAGR+17.2%

Ainos Inc invested $35K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 62.0% from the prior year.

AIMD Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$124K+499.0%	$21K-83.0%	$122K-96.5%	$3.5M+492.0%	$595K+3489.7%	$17K
Cost of Revenue	$21K-59.6%	$53K-86.0%	$376K-82.2%	$2.1M+1047.9%	$184K+1533.2%	$11K
Gross Profit	$103K+422.9%	-$32K+87.4%	-$254K-118.1%	$1.4M+242.4%	$410K+7663.6%	$5K
R&D Expenses	$947K-88.7%	$8.4M+15.0%	$7.3M+6.9%	$6.8M+256.4%	$1.9M+493639.1%	$389
SG&A Expenses	$6.3M+17.6%	$5.4M-4.3%	$5.6M-34.0%	$8.5M+262.1%	$2.4M+63.1%	$1.4M
Operating Income	-$14.0M-1.1%	-$13.8M-4.8%	-$13.2M+5.5%	-$14.0M-261.4%	-$3.9M-168.5%	-$1.4M
Interest Expense	$712K+15.5%	$616K+327.5%	$144K+169.4%	$54K+186.4%	$19K+74.6%	$11K
Income Tax	$8000.0%	$8000.0%	$800	$0	N/A	$0
Net Income	-$14.8M+0.6%	-$14.9M-7.9%	-$13.8M+1.7%	-$14.0M-260.2%	-$3.9M-168.1%	-$1.5M
EPS (Diluted)	$-3.46-121.8%	$-1.56+53.6%	$-3.36	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$2K-53.5%	$5K-95.6%	$106K	N/A	N/A	N/A	$21K+4.1%	$20K
Cost of Revenue	$477-49.1%	$937-94.9%	$18K	N/A	$547-97.8%	$25K-5.2%	$27K-79.6%	$131K
Gross Profit	$2K-54.6%	$4K-95.8%	$88K	N/A	-$547+97.8%	-$25K-321.1%	-$6K+94.6%	-$111K
R&D Expenses	$2.0M+4.1%	$1.9M+10.9%	$1.7M	N/A	$2.0M+2.2%	$2.0M-5.1%	$2.1M-6.8%	$2.2M
SG&A Expenses	$795K-56.7%	$1.8M+20.4%	$1.5M	N/A	$1.0M-2.8%	$1.0M+1.5%	$1.0M-69.3%	$3.4M
Operating Income	-$2.8M+25.7%	-$3.7M-18.4%	-$3.2M	N/A	-$3.0M+0.3%	-$3.0M+2.3%	-$3.1M+45.3%	-$5.7M
Interest Expense	$177K-0.8%	$178K-1.4%	$180K	N/A	$265K+122.8%	$119K+143.9%	$49K-3.3%	$50K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$2.9M+28.2%	-$4.1M-24.3%	-$3.3M	N/A	-$3.7M-15.8%	-$3.2M+3.6%	-$3.3M+44.0%	-$5.9M
EPS (Diluted)	$-0.64+35.4%	$-0.99-371.4%	$-0.21	N/A	$-1.64+33.1%	$-2.45-329.8%	$-0.57	N/A

AIMD Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	N/A	$28.8M-9.5%	$31.8M-14.2%	$37.1M-9.1%	$40.8M+15583.3%	$260K
Current Assets	N/A	$4.3M+75.4%	$2.5M-13.1%	$2.8M+28.3%	$2.2M+2802.3%	$76K
Cash & Equivalents	N/A	$3.9M+106.5%	$1.9M+1.7%	$1.9M+5.8%	$1.8M+7773.7%	$22K
Inventory	N/A	$144K-14.2%	$168K-71.8%	$595K	$0	$0
Accounts Receivable	N/A	$56-87.7%	$455-99.8%	$202K	$0	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	N/A	$13.3M+79.9%	$7.4M+198.0%	$2.5M-91.9%	$30.6M+2687.7%	$1.1M
Current Liabilities	N/A	$4.0M+195.8%	$1.3M-45.9%	$2.5M-91.9%	$30.6M+2685.0%	$1.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	N/A	$15.5M-36.5%	$24.4M-29.4%	$34.6M+239.6%	$10.2M+1316.4%	-$838K
Retained Earnings	N/A	-$52.7M-39.2%	-$37.9M-57.1%	-$24.1M-138.6%	-$10.1M-62.5%	-$6.2M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$22.7M-5.2%	$23.9M-9.2%	$26.4M-8.6%	$28.8M-8.1%	$31.4M-11.7%	$35.5M+19.4%	$29.8M-6.6%	$31.8M
Current Assets	$1.7M-0.8%	$1.7M-43.2%	$3.1M-29.7%	$4.3M-23.2%	$5.6M-33.3%	$8.5M+461.3%	$1.5M-39.0%	$2.5M
Cash & Equivalents	$1.1M-7.8%	$1.2M-53.5%	$2.6M-32.5%	$3.9M-24.5%	$5.2M-35.7%	$8.0M+677.4%	$1.0M-45.3%	$1.9M
Inventory	$167K+4.3%	$160K+12.9%	$142K-1.3%	$144K-10.5%	$161K-3.4%	$166K-2.0%	$170K+1.2%	$168K
Accounts Receivable	$62-66.8%	$187+105.5%	$91+62.5%	$56	N/A	$9-99.8%	$4K+816.9%	$455
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$12.6M+1.2%	$12.5M-5.7%	$13.2M-0.5%	$13.3M-0.3%	$13.3M-10.0%	$14.8M+109.6%	$7.1M-4.3%	$7.4M
Current Liabilities	$581K-3.6%	$603K-60.4%	$1.5M-61.5%	$4.0M-4.3%	$4.1M-28.1%	$5.7M+22.0%	$4.7M+252.0%	$1.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$10.0M-12.2%	$11.4M-12.8%	$13.1M-15.4%	$15.5M-13.9%	$18.0M-13.0%	$20.7M-8.7%	$22.7M-7.2%	$24.4M
Retained Earnings	-$63.1M-4.9%	-$60.1M-7.3%	-$56.0M-6.2%	-$52.7M-9.7%	-$48.1M-8.3%	-$44.4M-7.8%	-$41.2M-8.7%	-$37.9M

AIMD Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$4.6M+20.5%	-$5.8M-23.7%	-$4.7M-54.4%	-$3.0M-143.3%	-$1.2M-150.2%	-$500K
Capital Expenditures	$35K+62.0%	$21K-77.1%	$93K-85.3%	$634K+340.8%	$144K	$0
Free Cash Flow	-$4.6M+20.2%	-$5.8M-21.8%	-$4.8M-30.3%	-$3.7M-163.6%	-$1.4M-179.0%	-$500K
Investing Cash Flow	-$2K+98.2%	-$125K-23.4%	-$102K+83.9%	-$630K-249.1%	-$181K-2392.3%	-$7K
Financing Cash Flow	$1.0M-87.4%	$8.0M+63.0%	$4.9M+27.9%	$3.9M+22.1%	$3.2M+2528.6%	$120K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$1.2M+12.3%	-$1.4M-10.3%	-$1.2M-41.7%	-$864K+41.4%	-$1.5M+25.3%	-$2.0M-32.1%	-$1.5M-8.9%	-$1.4M
Capital Expenditures	$10K+231.9%	-$8K-122.9%	$34K+3604.8%	$908-91.1%	$10K+73.5%	$6K+32.1%	$4K+129.8%	-$15K
Free Cash Flow	-$1.2M+12.0%	-$1.4M-7.9%	-$1.3M-45.4%	-$865K+41.8%	-$1.5M+25.0%	-$2.0M-32.1%	-$1.5M-8.0%	-$1.4M
Investing Cash Flow	$5K+94.1%	$3K+112.3%	-$21K-255.0%	$13K+170.7%	-$19K-120.7%	-$9K+92.4%	-$111K-795.4%	$16K
Financing Cash Flow	$1.1M+483.6%	-$296K-2123.3%	$15K+105.4%	-$270K+81.8%	-$1.5M-116.5%	$9.0M+1057.6%	$778K-13.6%	$900K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

AIMD Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	82.9%+236.6pp	-153.7%+54.1pp	-207.8%-247.7pp	39.9%-29.1pp	69.0%+37.1pp	31.9%
Operating Margin	-11268.3%+55503.9pp	-66772.2%-55957.2pp	-10815.0%-10417.9pp	-397.1%+253.4pp	-650.5%+8046.2pp	-8696.7%
Net Margin	-11897.0%+59805.2pp	-71702.3%-60425.3pp	-11277.0%-10879.0pp	-398.0%+256.1pp	-654.0%+8104.2pp	-8758.2%
Return on Equity	N/A	-95.8%-39.5pp	-56.3%-15.9pp	-40.5%-2.3pp	-38.1%	N/A
Return on Assets	N/A	-51.6%-8.3pp	-43.3%-5.5pp	-37.7%-28.2pp	-9.5%+547.8pp	-557.3%
Current Ratio	N/A	1.10-0.8	1.85+0.7	1.15+1.1	0.070.0	0.07
Debt-to-Equity	N/A	0.86+0.6	0.30+0.2	0.07-2.9	3.00+4.3	-1.31
FCF Margin	-3744.7%+24378.3pp	-28122.9%-24202.2pp	-3920.7%-3816.3pp	-104.4%+130.0pp	-234.4%+2781.6pp	-3016.1%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	78.0%-1.9pp	79.9%-2.9pp	82.8%	N/A	N/A	N/A	-29.1%+530.6pp	-559.7%
Operating Margin	-128481.4%-48153.6pp	-80327.8%-77349.8pp	-2978.0%	N/A	N/A	N/A	-15051.8%+13591.2pp	-28643.0%
Net Margin	-135288.5%-47684.2pp	-87604.3%-84510.4pp	-3094.0%	N/A	N/A	N/A	-15991.2%+13774.2pp	-29765.4%
Return on Equity	-29.2%+6.5pp	-35.7%-10.7pp	-25.0%	N/A	-20.5%-5.1pp	-15.4%-0.8pp	-14.6%+9.6pp	-24.2%
Return on Assets	-12.9%+4.2pp	-17.1%-4.6pp	-12.5%	N/A	-11.8%-2.8pp	-9.0%+2.2pp	-11.1%+7.5pp	-18.6%
Current Ratio	2.96+0.1	2.88+0.9	2.00+0.9	1.10-0.3	1.37-0.1	1.48+1.2	0.32-1.5	1.85
Debt-to-Equity	1.26+0.2	1.09+0.1	1.01+0.2	0.86+0.1	0.74+0.0	0.72+0.4	0.310.0	0.30
FCF Margin	-55137.0%-26011.7pp	-29125.3%-27940.6pp	-1184.7%	N/A	N/A	N/A	-7232.3%-259.8pp	-6972.5%

Similar Companies

Intelligent Bio Solutions Inc INBS

$5.5M

ALLURION TECHNOLOGIES INC ALUR

$10.0M

Trinity Biotech Plc TRIB

$11.4M

Envveno Medical Corporation NVNO

$6.9M

Nexalin Tech NXL

$7.2M

Frequently Asked Questions

What is Ainos Inc's annual revenue?

Ainos Inc (AIMD) reported $124K in total revenue for fiscal year 2025. This represents a 499.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Ainos Inc's revenue growing?

Ainos Inc (AIMD) revenue grew by 499% year-over-year, from $21K to $124K in fiscal year 2025.

Is Ainos Inc profitable?

No, Ainos Inc (AIMD) reported a net income of -$14.8M in fiscal year 2025, with a net profit margin of -11897.0%.

What is Ainos Inc's EBITDA?

Ainos Inc (AIMD) had EBITDA of -$9.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Ainos Inc's gross margin?

Ainos Inc (AIMD) had a gross margin of 82.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Ainos Inc's operating margin?

Ainos Inc (AIMD) had an operating margin of -11268.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Ainos Inc's net profit margin?

Ainos Inc (AIMD) had a net profit margin of -11897.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Ainos Inc's free cash flow?

Ainos Inc (AIMD) generated -$4.6M in free cash flow during fiscal year 2025. This represents a 20.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Ainos Inc's operating cash flow?

Ainos Inc (AIMD) generated -$4.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Ainos Inc's capital expenditures?

Ainos Inc (AIMD) invested $35K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Ainos Inc spend on research and development?

Ainos Inc (AIMD) invested $947K in research and development during fiscal year 2025.

How many shares does Ainos Inc have outstanding?

Ainos Inc (AIMD) had 7M shares outstanding as of fiscal year 2025.

Are Ainos Inc's earnings high quality?

Ainos Inc (AIMD) has an earnings quality ratio of 0.31x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Ainos Inc cover its interest payments?

Ainos Inc (AIMD) has an interest coverage ratio of -19.7x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.